Advertisement

Mansfield, Conn.-based Biorasis Inc. has received a one-year, $486,000 Small Business Innovation Research Phase 2 grant award to continue developing a self-calibrating, wireless, needle-implantable sensor for continuous glucose monitoring.

Advertisement
Advertisement